MDT - CIK 0001613103
The table below shows Medtronic plc's cash flow statement line items across its last 6 fiscal years, exactly as reported in the company's audited annual filings. All figures are in US dollars; negative values appear in red.
| Line item | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 |
|---|---|---|---|---|---|---|
| Operating cash flow | $7.04B | $6.79B | $6.04B | $7.35B | $6.24B | $7.23B |
| Capital expenditure | $1.86B | $1.59B | $1.46B | $1.37B | $1.35B | $1.21B |
| Investing cash flow | -$1.94B | -$2.37B | -$3.49B | -$1.66B | -$2.87B | -$3.20B |
| Dividends paid | $3.59B | $3.67B | $3.62B | $3.38B | $3.12B | $2.89B |
Medtronic plc reported operating cash flow of $7.04B for fiscal year 2025. That is up 3.8% from $6.79B in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from $5.22B (FY 2016) to $7.04B. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| Stock buybacks | $3.23B | $2.14B | $645.00M | $2.54B | $652.00M | $1.33B |
| Financing cash flow | -$4.36B | -$4.45B | -$4.96B | -$5.34B | -$4.14B | -$4.20B |